Verve Therapeutics, Inc. (VERV) Accrued Liabilities, Current USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Verve Therapeutics, Inc. quarterly Accrued Liabilities, Current history and growth rate from 2020 to 2024.
Verve Therapeutics, Inc. Accrued Liabilities, Current for the quarter ending March 31, 2024 was $16.6M, a 12.9% decline year-over-year.

Accrued Liabilities, Current, Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$16.6M	-$2.44M	-12.9%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$20.2M	-$589K	-2.84%	Dec 31, 2023	10-Q	2024-05-08
Q3 2023	$23.4M	+$3.75M	+19.1%	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$19.8M	+$1.22M	+6.55%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$19M	+$8.06M	+73.7%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$20.8M	+$7.78M	+59.8%	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$19.6M	+$11.5M	+142%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$18.6M	+$11.7M	+167%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$10.9M			Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$13M	+$5.8M	+80.7%	Dec 31, 2021	10-K	2023-03-02
Q3 2021	$8.13M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$6.97M			Jun 30, 2021	10-Q/A	2021-08-16
Q4 2020	$7.19M			Dec 31, 2020	10-K	2022-03-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.